Wednesday, July 17, 2019

Pharma Reviews: US FDA finds "significant violations" at India's Strides plant

The US Food and Drug Administration (FDA) said it found adulteration and "significant violations" of current good manufacturing practice (CGMP) ...
Read more: US FDA finds "significant violations" at India's Strides plant